These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 34752267)
1. Intrauterine Device Insertion and Removal. Long S; Colson L Prim Care; 2021 Dec; 48(4):531-544. PubMed ID: 34752267 [TBL] [Abstract][Full Text] [Related]
2. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs. Chi IC Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615 [TBL] [Abstract][Full Text] [Related]
3. Acceptability of an experimental intracervical device: results of a study controlling for selection bias. Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982 [TBL] [Abstract][Full Text] [Related]
4. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices. Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785 [TBL] [Abstract][Full Text] [Related]
5. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system. Suvisaari J; Lähteenmäki P Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872 [TBL] [Abstract][Full Text] [Related]
14. The Intrauterine Device Experience Among Transgender and Gender-Diverse Individuals Assigned Female at Birth. Abern L; Krempasky C; Diego D; De Guzman G; Kiely K; Cook J; Maguire K J Midwifery Womens Health; 2021 Nov; 66(6):772-777. PubMed ID: 34767305 [TBL] [Abstract][Full Text] [Related]
15. Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa. Beesham I; Bosman S; Beksinska M; Scoville CW; Smit J; Nanda K Contraception; 2022 Apr; 108():37-43. PubMed ID: 34848180 [TBL] [Abstract][Full Text] [Related]
16. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study. Luukkainen T; Allonen H; Haukkamaa M; Holma P; Pyörälä T; Terho J; Toivonen J; Batar I; Lampe L; Andersson K Contraception; 1987 Aug; 36(2):169-79. PubMed ID: 3123132 [TBL] [Abstract][Full Text] [Related]
17. One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception. Sanders JN; Turok DK; Royer PA; Thompson IS; Gawron LM; Storck KE Contraception; 2017 Aug; 96(2):99-105. PubMed ID: 28596121 [TBL] [Abstract][Full Text] [Related]
18. Safety of levonorgestrel 52 mg intrauterine system compared to copper intrauterine device: a population-based cohort study. Bosco-Lévy P; Gouverneur A; Langlade C; Miremont G; Pariente A Contraception; 2019 Jun; 99(6):345-349. PubMed ID: 30871933 [TBL] [Abstract][Full Text] [Related]
19. Obstetrician-gynecologists and contraception: long-acting reversible contraception practices and education. Luchowski AT; Anderson BL; Power ML; Raglan GB; Espey E; Schulkin J Contraception; 2014 Jun; 89(6):578-83. PubMed ID: 24656553 [TBL] [Abstract][Full Text] [Related]
20. Intrauterine devices: an effective alternative to oral hormonal contraception. Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]